Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
42.45
-0.01 (-0.02%)
Apr 21, 2026, 4:00 PM EDT - Market closed

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2623,1471,4341,2361,044813
Market Cap Growth
120.58%119.41%16.06%18.37%28.45%-32.56%
Enterprise Value
2,8582,7401,1991,040856.08633.31
Last Close Price
42.4541.2519.7817.5414.9811.77
PE Ratio
56.6055.00-32.9787.705.76-5.12
Forward PE
41.3527.3242.93---
PS Ratio
4.814.643.394.574.7421.09
PB Ratio
5.715.543.272.822.644.39
P/TBV Ratio
5.905.743.222.882.664.36
P/FCF Ratio
23.9223.0756.4493.83183.11-6.41
P/OCF Ratio
23.6422.8155.8492.92179.80-6.44
EV/Sales Ratio
4.224.042.833.853.8916.43
EV/EBITDA Ratio
36.2834.78-27.29-45.4870.31-4.10
EV/EBIT Ratio
37.0135.48-26.28-41.2687.60-4.04
EV/FCF Ratio
20.9520.0847.1778.92150.14-5.00
Debt / Equity Ratio
0.010.010.020.020.010.01
Debt / EBITDA Ratio
0.120.12-0.22-0.540.49-0.04
Debt / FCF Ratio
0.070.070.390.931.04-0.05
Net Debt / Equity Ratio
-0.71-0.71-0.53-0.44-0.47-0.95
Net Debt / EBITDA Ratio
-5.14-5.145.328.49-15.171.14
Net Debt / FCF Ratio
-2.97-2.97-9.20-14.74-32.391.39
Asset Turnover
1.011.010.760.550.640.13
Inventory Turnover
1.911.912.121.271.814.95
Quick Ratio
3.093.092.843.584.484.15
Current Ratio
3.793.793.304.345.164.38
Return on Equity (ROE)
11.73%11.73%-9.85%3.37%63.10%-63.55%
Return on Assets (ROA)
15.35%15.35%-6.64%-14.54%-41.30%-53.33%
Return on Invested Capital (ROIC)
42.12%42.12%-14.09%-28.79%-118.29%-4448.43%
Return on Capital Employed (ROCE)
13.98%13.98%-9.68%-5.76%3.25%-61.96%
Earnings Yield
1.81%1.82%-3.03%1.14%17.36%-19.54%
FCF Yield
4.18%4.33%1.77%1.07%0.55%-15.59%
Buyback Yield / Dilution
-10.58%-10.58%0.69%-2.13%-2.69%-10.89%
Total Shareholder Return
-10.58%-10.58%0.69%-2.13%-2.69%-10.89%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q